CHARACTERISTICS AND CLINICAL OUTCOMES OF END-STAGE RENAL DISEASE PATIENTS ON PERITONEAL DIALYSIS FOR OVER 15 YEARS: A SINGLE-CENTER EXPERIENCE

被引:5
|
作者
Kee, Youn Kyung [1 ]
Park, Jung Tak [2 ]
Yoon, Chang-Yun [2 ]
Kim, Hyoungnae [2 ]
Park, Seohyun [2 ]
Yun, Hae Ryong [2 ]
Jung, Su-Young [2 ]
Jhee, Jong Hyun [2 ]
Oh, Hyung Jung [2 ]
Han, Seung Hyeok [2 ]
Yoo, Tae-Hyun [2 ]
Kang, Shin-Wook [2 ,3 ]
机构
[1] Yonsei Univ, Grad Sch Med, Dept Med, Seoul, South Korea
[2] Inst Kidney Dis Res, Coll Med, Dept Internal Med, Seoul, South Korea
[3] Inst Kidney Dis Res, Brain Korea PLUS 21, Severance Biomed Sci Inst, Seoul, South Korea
来源
PERITONEAL DIALYSIS INTERNATIONAL | 2017年 / 37卷 / 05期
关键词
End-stage renal failure; long-term peritoneal dialysis; clinical outcomes; TECHNIQUE FAILURE; LONG; CAPD; SURVIVAL; ADEQUACY; RISK; SCLEROSIS; TRANSPORT; THERAPY; IMPACT;
D O I
10.3747/pdi.2016.00227
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Maintaining peritoneal dialysis (PD) for a long time is problematic owing to a number of factors. This study aimed to clarify the characteristics and examine the clinical outcomes of patients who received PD as a long-term dialysis modality. Methods: All end-stage renal disease (ESRD) patients who initiated PD at Yonsei University Health System between 1987 and 2000 were screened. Patients who maintained PD for over 15 years were classified as the long-term PD group and those who were treated with PD for less than 5 years were included in the short-term PD group. Demographic and biochemical data and clinical outcomes were compared between the groups. Independent factors associated with long-term PD maintenance were ascertained using multivariate logistic regression analysis. Results: Among 1,116 study patients, 87 (7.8%) were included in the long-term group and 293 (26.3%) were included in the short-term group. In the long-term group, the mean patient age at PD initiation was 39.6 +/- 11.5 years, 35 patients (40.2%) were male, and the mean PD duration was 205.3 +/- 32.7 months. Patients were younger, body weight was lower, the proportion of patients with diabetes or cardiovascular diseases was lower, and the proportion of low to low-average transporters was higher in the long-term group than in the short-term group (p < 0.001). Multiple logistic regression analysis revealed that age, body mass index (BMI), serum creatinine, type of PD solution, and diabetes were significant independent factors associated with long-term PD maintenance. Conclusion: Peritoneal dialysis can be considered as a long-term renal replacement therapy option, especially in non-diabetic, not overweight, and young ESRD patients.
引用
收藏
页码:535 / 541
页数:7
相关论文
共 50 条
  • [41] Cost Comparison of Peritoneal Dialysis Versus Hemodialysis in End-Stage Renal Disease
    Berger, Ariel
    Edelsberg, John
    Inglese, Gary W.
    Bhattacharyya, Samir K.
    Oster, Gerry
    AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (08) : 509 - 518
  • [42] Comparison of peritoneal dialysis and hemodialysis as first renal replacement therapy in patients with end-stage renal disease and diabetes: a systematic review
    Maruyama, Yukio
    Higuchi, Chieko
    Io, Hiroaki
    Wakabayashi, Keiichi
    Tsujimoto, Hiraku
    Tsujimoto, Yasushi
    Yuasa, Hidemichi
    Ryuzaki, Munekazu
    Ito, Yasuhiko
    Nakamoto, Hidetomo
    RENAL REPLACEMENT THERAPY, 2019, 5 (01)
  • [43] Dialysis modality and 2-year outcomes in patients with ischemic cardiomyopathy and end-stage renal disease
    Panday, Vinay Bahadur
    Tong, Zi-Ping
    Ng, Perryn L.
    Lee, Evan J.
    Lau, Titus
    Teo, Boon-Wee
    Chua, Horng-Ruey
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (03) : 1097 - 1099
  • [44] Peritonitis outcomes in patients with HIV and end-stage renal failure on peritoneal dialysis: a prospective cohort study
    Kwazi C. Z. Ndlovu
    Wilbert Sibanda
    Alain Assounga
    BMC Nephrology, 18
  • [45] Trimethylamine-N-oxide (TMAO) and clinical outcomes in patients with end-stage kidney disease receiving peritoneal dialysis
    Chang, Dongyuan
    Xu, Xiao
    Yang, Zhikai
    Ma, Tiantian
    Nie, Jing
    Dong, Jie
    PERITONEAL DIALYSIS INTERNATIONAL, 2022, 42 (06): : 622 - 630
  • [46] Experience with Trabectedin in an Advanced Sarcoma Patient on Peritoneal Dialysis for End-Stage Renal Failure
    Moe, Maung Maung Myat
    Fernandez Teruel, Carlos
    Soto-Matos, Arturo
    CHEMOTHERAPY, 2013, 59 (06) : 458 - 460
  • [47] Cardiac surgery in patients with end-stage renal disease on dialysis
    Back, Caroline
    Hornum, Mads
    Moller, Christian Joost Holdflod
    Olsen, Peter Skov
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (06) : 334 - 338
  • [48] Cancer Among End-Stage Renal Disease Patients on Dialysis
    Loy, En Yun
    Choong, Hui Lin
    Chow, Khuan Yew
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2013, 42 (12) : 640 - 645
  • [49] Hemodialysis versus Peritoneal Dialysis: A Comparison of Survival Outcomes in South-East Asian Patients with End-Stage Renal Disease
    Yang, Fan
    Khin, Lay-Wai
    Lau, Titus
    Chua, Horng-Ruey
    Vathsala, A.
    Lee, Evan
    Luo, Nan
    PLOS ONE, 2015, 10 (10):
  • [50] Long-term blood pressure behavior and progression to end-stage renal disease in patients with immunoglobulin A nephropathy: a single-center observational study in Italy
    Russo, Elisa
    Verzola, Daniela
    Salvidio, Gennaro
    Bonino, Barbara
    Picciotto, Daniela
    Drovandi, Stefania
    Pozzi, Claudio
    Ferrario, Francesca
    Pontremoli, Roberto
    Garibotto, Giacomo
    Viazzi, Francesca
    JOURNAL OF HYPERTENSION, 2020, 38 (05) : 925 - 935